Lanbelle Egf Fgf Ampule
NDC Package 72084-0005-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Lanbelle Egf Fgf Ampule is after using clear toner, take a drop in the forehead and the cheeks in the morning and the evening.It can be used in combination with LANBELLE hydrating duo serum. Marketed by Tamlatamanu Inc., this product is identified by NDC 72084-0005 and is authorized under FDA application part347.

Identification & Billing

NDC Package Code
72084-0005-1
Package Description
15 mL in 1 BOTTLE, DROPPER
Product Code
11-Digit Billing Format
72084000501

Clinical Specifications

Proprietary Name
Lanbelle Egf Fgf Ampule
Dosage Form
-
Usage Information
After using clear toner, take a drop in the forehead and the cheeks in the morning and the evening.It can be used in combination with LANBELLE hydrating duo serum.

Regulatory & Marketing

Labeler Name
Tamlatamanu Inc.
FDA Application #
part347
Marketing Category
OTC MONOGRAPH NOT FINAL - A product marketed pursuant to an Over-the-Counter (OTC) Drug Monograph that is not final.
Start Marketing Date
03-27-2018
Listing Expiration
12-31-2019
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 72084-0005-1 identifies a specific commercial package of 15 ml in 1 bottle, dropper of Lanbelle Egf Fgf Ampule, labeled by Tamlatamanu Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Tamlatamanu Inc. on March 27, 2018. The current certification is valid through December 31, 2019.

How is this Tamlatamanu Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 72084000501. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
72084-0005-1
11-Digit CMS (5-4-2)
72084-0005-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.